Business Description
Dae Hwa Pharm Co Ltd
ISIN : KR7067080002
Share Class Description:
XKRX:067080: Ordinary SharesCompare
Compare
Traded in other countries / regions
067080.Korea IPO Date
2003-02-14Description
Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.6 | |||||
Debt-to-EBITDA | 13.96 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.37 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.2 | |||||
3-Year EBITDA Growth Rate | -1.3 | |||||
3-Year EPS without NRI Growth Rate | 8.7 | |||||
3-Year FCF Growth Rate | -12.3 | |||||
3-Year Book Growth Rate | -3.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.21 | |||||
9-Day RSI | 67.83 | |||||
14-Day RSI | 63.86 | |||||
6-1 Month Momentum % | 13 | |||||
12-1 Month Momentum % | 24.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.5 | |||||
Quick Ratio | 0.27 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 103.24 | |||||
Days Sales Outstanding | 51.23 | |||||
Days Payable | 50.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.34 | |||||
Forward Dividend Yield % | 1.34 | |||||
5-Year Yield-on-Cost % | 1.34 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -7.61 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 31.18 | |||||
Operating Margin % | -0.15 | |||||
Net Margin % | -2.9 | |||||
FCF Margin % | -6.24 | |||||
ROE % | -5.58 | |||||
ROA % | -1.93 | |||||
ROIC % | -0.09 | |||||
ROC (Joel Greenblatt) % | 1.42 | |||||
ROCE % | 1.68 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 47.68 | |||||
PS Ratio | 1.39 | |||||
PB Ratio | 2.82 | |||||
Price-to-Tangible-Book | 4.78 | |||||
Price-to-Operating-Cash-Flow | 228 | |||||
EV-to-EBIT | 175.54 | |||||
EV-to-EBITDA | 36.97 | |||||
EV-to-Revenue | 2.07 | |||||
EV-to-FCF | -32.59 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Earnings Yield (Greenblatt) % | 0.57 | |||||
FCF Yield % | -4.52 | |||||
Forward Rate of Return (Yacktman) % | -24.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dae Hwa Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 143,526.796 | ||
EPS (TTM) (â‚©) | -237 | ||
Beta | 0.02 | ||
Volatility % | 96.95 | ||
14-Day RSI | 63.86 | ||
14-Day ATR (â‚©) | 537.845541 | ||
20-Day SMA (â‚©) | 10500 | ||
12-1 Month Momentum % | 24.33 | ||
52-Week Range (â‚©) | 7390 - 15980 | ||
Shares Outstanding (Mil) | 17.52 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Dae Hwa Pharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Dae Hwa Pharm Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Dae Hwa Pharm Co Ltd Frequently Asked Questions
What is Dae Hwa Pharm Co Ltd(XKRX:067080)'s stock price today?
The current price of XKRX:067080 is â‚©11300.00. The 52 week high of XKRX:067080 is â‚©15980.00 and 52 week low is â‚©7390.00.
When is next earnings date of Dae Hwa Pharm Co Ltd(XKRX:067080)?
The next earnings date of Dae Hwa Pharm Co Ltd(XKRX:067080) is .
Does Dae Hwa Pharm Co Ltd(XKRX:067080) pay dividends? If so, how much?
The Dividend Yield %  of Dae Hwa Pharm Co Ltd(XKRX:067080) is 1.34% (As of Today), Highest Dividend Payout Ratio of Dae Hwa Pharm Co Ltd(XKRX:067080) was 3.3. The lowest was 0.21. And the median was 0.57. The  Forward Dividend Yield % of Dae Hwa Pharm Co Ltd(XKRX:067080) is 1.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |